Cellular zinc transport has not been fully characterized. The role of an anion carrier was investigated by treating normal Ž . human fibroblasts, and those carrying a mutation which affects zinc transport, acrodermatitis enteropathica AE , with the Ž y1 65
Introduction
The cellular mechanism for zinc uptake has not been fully characterized. One aspect of cellular zinc uptake appears to involve an anion carrier system. Zinc uptake into human erythrocytes is stimulated by bicarbonate and chloride, and inhibited by the band 3 anion exchange inhibitor 4,4 X -diiosthiocyanatostil-X Ž . w x bene-2,2 -disulphonic acid DIDS 1,2 . The transported complex has been proposed to be w Ž . x y w x y w Ž . Zn HCO Cl 1 , ZnCO Cl or Zn HCO Cl P 3 2 3 3
) Corresponding author. Fax: q1-706-5425059; E-mail: agrider@fcs.uga.edu x y w x OH 2 . Bicarbonate also stimulates zinc uptake w x into human fibroblasts 3 . Brush border membrane vesicles from pig small intestine also appear to transport zinc via an anion carrier system, although a w x thiocyanate complex was the anionic species 4-6 . However, this mechanism was not DIDS sensitive w x 6 .
Anion transport mechanisms other than those sensitive to DIDS have been identified. These include w x w a-cyano-4-hydroxycinnamate 7 and r-dipropylsulx Ž .w x famoyl benzoic acid probenecid 8-10 . The mechanism of inhibition of these inhibitors on cellular zinc transport has not been investigated. Probenecid inhibits cellular folate and methotrexate transport by w x L1210 and MA104 cells 9,10 . Furthermore, a 0005-2736r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
Ž . PII S0005-2736 97 00170-3 ( )probenecid-sensitive anion transport mechanism has been proposed in the model for non-clathrin coated w x pit vesicular transport, termed potocytosis 11,12 . We have previously reported that nystatin, a sterol-binding antibiotic that inhibits the formation of caveo-Ž . lae the vesicles of potocytosis , also inhibits zinc w x transport 13 . If zinc transport occurs via potocytosis, it may also be inhibited by probenecid. Thus, we hypothesized that zinc transport would be inhibited by probenecid. Further, we also hypothesized that probenecid would inhibit further the poor zinc uptake by fibroblasts containing the acrodermatitis enteropathica mutation. We used these cells because we hypothesized that more than one mechanism might exist for zinc transport. Our results support these hypotheses. We found that cellular zinc transport occurs through a probenecid-sensitive anion carrier, suggesting that potocytosis is involved. However, the results also suggest the existence of a secondary zinc uptake system. The AE mutation significantly inhibited zinc uptake but probenecid treatment did not further reduce zinc transport in these cells.
Materials and methods

Cell culture
Fibroblasts were purchased from the Coriell Institute for Medical Research Genetic Mutant Cell Ž . Repository Camden, NJ . Fibroblasts were from Ž . Caucasian males. The normal fibroblasts GM5659B were obtained from a 14 month old infant. Acroder-Ž . matitis enteropathica GM2814 fibroblasts were from a 6 month old infant. The cells were grown in Ž . Ž minimal essential medium Eagle's GIBCO-BRL, .
y1
Grand Island, NY containing 0.01 mg l gentamicin, 0.06 g l y1 penicillin, 0.1 g l y1 streptomycin, 20% uninactivated fetal calf serum and double the normal concentrations of essential and non-essential amino acids and vitamins. The growth medium contained approximately 16 mmol l y1 zinc as measured by atomic absorption spectroscopy.
Zinc transport
The fibroblasts were subcultured in 3.83 cm 2 dishes Ž . incubated at 378C for 20 min with HGS buffer or buffer containing 10 or 20 mmol l y1 probenecid, pH 7.5. These concentrations of probenecid were chosen because 10 mmol l y1 has been shown to inhibit w x folate transport in MA104 cells 10 . The effect on zinc transport of 20 mmol l y1 probenecid was investigated to determine whether maximal inhibition of zinc transport was obtained at 10 mmol l y1 probenecid.
The incubation buffer was removed and the cells were incubated for 15 min with fresh buffers at 378C y1 65
Ž
. containing 2 to 20 mmol l zinc 1 kBq . Previous results indicated that zinc uptake in these fibroblasts w x was linear between 10 and 30 min 22 , indicating that the 15 min time point is within the initial rate for zinc uptake. Carrier-free 65 zinc was used as a tracer Ž . Amersham, Arlington Heights, IL . Transport was stopped by placing the culture dishes on ice. The labeled buffer was removed and the fibroblasts were Ž y1 rinsed with 1 ml ice-cold EDTA buffer 10 mmol l HEPES, 150 mmol l y1 NaCl, 10 mmol l y1 EDTA, . pH 7.4 for 30 s. The reaction was stopped with the addition of 1 ml ice-cold HGS buffer. The buffers were removed and the cells rinsed with 1 ml ice-cold HGS. This buffer was removed and the cells were Ž rinsed for 30 s with ice-cold acidic saline 150 mmol y1 y1
. l NaCl, 40 mmol l acetic acid, pH 3.0 . The reaction was stopped by the addition of 1 ml ice-cold HGS. This rinse was removed and placed in scintillation vials. The HGS rinse was repeated and also placed with the acidic saline rinse, and the radioactivity of the solution determined by gamma counting. Preliminary experiments indicated that a single EDTA rinse removed 15.2% of the cell-associated label, compared to 17.6% of the cell-associated label after 4 EDTA rinses. A single acidic saline rinse removed 17.2% of the label compared to 19.29% of the label removed after four acidic saline rinses. However, a single rinse with EDTA followed by a single rinse with acidic saline removed 19.8% of the cell-associated zinc. Therefore, this method was chosen for determining externally bound and internalized zinc.
The cells were lysed by adding 0.2 M NaOH-0.2% ( )sodium dodecyl sulfate for 15 min at room temperature and freezing overnight at y208C. The lysate was thawed and the radioactivity determined by gamma counting. An aliquot was used for protein determinaw x tion with the bicinchoninic acid method 21 . The amount of zinc present in the acidic saline rinse represents externally-bound, acid-sensitive cellular zinc. The amount of zinc present in the NaOH-SDS solution represents internalized, acid-resistant zinc.
Data analysis and statistics
The data were analyzed by the Lineweaver-Burke double reciprocal plot. The intercepts of the x-axis or y-axis were used to determine the apparent K and m V , respectively. Significance was determined by max ANOVA and Student-Neuman-Keuls unpaired t-test Ž e . Statmost 1.01, DataMost, Salt Lake City, UT . Differences were considered significant when p -0.05.
Results
The accumulation of zinc by human fibroblasts, its binding to external binding sites, and its transport into human fibroblasts appeared to begin to saturate of zinc in the external compartment of these cells at 5 and 10 mmol l y1 zinc by 33% and 20%, respectively. AE fibroblasts treated with probenecid exhibited significant increases in total cell-associated zinc at all Ž . zinc concentrations Fig. 2A . Zinc accumulation in the external compartment was significant from 2 to The data are expressed as the mean"SE. The K and V were m m a x determined by fitting the curves generated from the data using the Lineweaver-Burke double reciprocal plot. The mean values for the data points in Fig. 1C were Table 1 . Normal fibroblasts exhibited a significant reduction in both kinetic parameters in the presence of probenecid. Probenecid treatment at 10 and 20 mmol l y1 reduced the apparent K by 53% and 44% compared to control, m respectively. Probenecid treatment at 10 and 20 mmol l y1 also reduced the V by 51% and 50% commax pared to control, respectively.
Discussion
The hypothesis tested by the present work was that probenecid would inhibit zinc transport in normal and ( )AE fibroblasts. The results from normal fibroblasts support the hypothesis, and are consistent with cellular zinc transport involving an anion carrier system. Probenecid has been used to identify the role of anion w x transport in the cellular uptake of folate 10 and w x methotrexate 9,14-16 , and may be associated with the vesicular transport mechanism called potocytosis w x 11 .
However, probenecid treatment did not inhibit zinc transport in the AE fibroblasts any further than was accounted for by the mutation alone. The results from these cells suggest that the probenecid-sensitive anion transport system may be the defect caused by the AE mutation. These results suggest that a secondary zinc transport system is available in the AE cells. Though not compensatory, this system is apparently capable of transporting sufficient zinc for relatively normal cellular function. However, the AE fibroblasts do contain less intracellular zinc and exhibit a reduction in the activity of the zinc-dependent enzyme, 5 X -nucleotidase, when compared with normal fibroblasts w x 22 .
The V and the apparent K measured in the max m normal cells were affected by probenecid treatment to the same degree, indicating that uncompetitive inhibiw x tion was occurring 17 . Probenecid apparently blocks the anion carrier, thereby restricting the transport of zinc into the cell. The reduced transport appears to increase the availability of extracellular zinc-binding sites, as indicated by an increase in the presence of zinc in the acid-sensitive compartment in the probenecid-treated cells. It is not known whether probenecid forms a complex with zinc, thereby affecting its binding to the cell surface. However, if this were so one might expect similar reductions in the internalization of zinc with probenecid treatment regardless of the genotype of the cell. The results in Fig. 1C and Fig. 2C indicate that probenecid only inhibited zinc internalization in the normal fibroblasts, not in the AE fibroblasts.
The model of potocytosis for the transmembrane transport of folate, and for zinc, involves the formation of vesicles through a cholesterol-dependent process, the activation of a monensin-sensitive proton pump, and transport through a probenecid-sensitive w x anion carrier 11 . Previous results from this lab indicate that cellular zinc transport in fibroblasts is w x inhibited by nystatin 13 , a membrane sterol-binding drug which also inhibits the formation of the potocyw x totic vesicles called caveolae 18 . Furthermore, the depletion of cellular cholesterol, i.e., the reduction in the number of functional caveolae, significantly reduces the cellular accumulation of folate and affects w x the internalization of the folate receptor 19,20 . The depletion of cellular cholesterol also reduces the cel-Ž . lular uptake of zinc Grider, unpublished data . Therefore, the data support the hypothesis that potocytosis may be involved in the transmembrane transport of zinc.
